Jeffrey T L Smith

Insider Reports History

Location
Bothell, WA
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey T L Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zymeworks Inc. EVP & Chief Medical Officer Restricted Stock Unit 35,334 $790,977 $14.92 12 Jan 2026 Direct
Zymeworks Inc. EVP & Chief Medical Officer Common Stock 26,708 $605,563 $22.67 12 Jan 2026 Direct

Insider Reports Filed by Jeffrey T L Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZYME Zymeworks Inc. 12 Jan 2026 3 -$211,090 4 EVP & Chief Medical Officer 12 Jan 2026, 21:00
ZYME Zymeworks Inc. 05 Jan 2026 3 -$264,471 4 EVP & Chief Medical Officer 05 Jan 2026, 20:22
ZYME Zymeworks Inc. 10 Jan 2025 2 $0 4 EVP & Chief Medical Officer 10 Jan 2025, 18:03
ZYME Zymeworks Inc. 06 Jan 2025 3 -$165,807 4 EVP & Chief Medical Officer 06 Jan 2025, 20:19
ZYME Zymeworks Inc. 05 Jan 2024 2 $0 4 EVP & Chief Medical Officer 08 Jan 2024, 18:00
ZYME Zymeworks Inc. 03 Jan 2024 0 $0 3 EVP & Chief Medical Officer 05 Jan 2024, 18:00